FDA Meeting Will Focus On Aggregating Patient-Generated Health Data
Executive Summary
The topic is central to the Patient Engagement Advisory Committee, which recently got its tenure extended. It also fits into the FDA’s thinking on real-world evidence and total product lifecycle approach.